A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Israeli Medical Association
- Target Recruit Count
- 48
- Registration Number
- NCT05054465
- Locations
- ๐ฎ๐ฑ
Shaare Zedek Medical Center, Jerusalem, Israel
๐ฎ๐ฑSoroka Medical Center, Be'er Sheva, Israel
๐ฎ๐ฑRabin Medical Center, Petah Tikva, Israel
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Israeli Medical Association
- Target Recruit Count
- 110
- Registration Number
- NCT04334993
- Locations
- ๐ฎ๐ฑ
Rambam Medical Center, Haifa, Israel
๐ฎ๐ฑShaarei Tzedek Medical Center, Jerusalem, Israel
๐ฎ๐ฑRabin Medical Center, Petah Tikva, Israel
ยฉ Copyright 2024. All Rights Reserved by MedPath